(1) “Act” means this act and any rule or regulation adopted hereunder.

(2) “Person” means any natural person, partnership, association, corporation, institution, agency, or other similar type entity.

(3) “Blood bank” means any place, organization, institution or establishment that it operated wholly or in part for the purpose of obtaining, storing, processing, preparing for transfusing, or selling human blood or parts or fractions of single blood units or products derived from single blood units, whether such procedures are done for direct therapeutic use or for storage for future use of such products, and whether a place, organization, institution, or establishment is operated on a charitable, commercial, or nonprofit basis.

(4) “Department” means the Department of Health of the Commonwealth of Pennsylvania.

(5) “Secretary” means the Secretary of the Department of Health of the Commonwealth of Pennsylvania.

(6) “Blood product” means any part or fraction of single units of whole human blood, or any material derived from single units of such blood which is subsequently administered to human subjects.

(7) “Collection” means the obtaining of blood by the bleeding of donors by a phlebotomy or plasmapheresis.

(8) “Processing” means the standards governing the technical procedures required to prepare and identify the blood as to its suitability for transfusing, including the performance of tests to screen out any communicable diseases.

(9) “Storage” means the holding of blood in connection with collection or processing prior to the distribution of transfusion.

(10) “Distribution” means the removal of blood from a blood bank to any other location for processing or storage for the purpose of providing the blood for therapeutic or prophylactic purposes.

(11) “Licensee” means a person holding a license under the provisions of this act.

(12) “Screening of donors” means the evaluation of prospective donors by the blood bank to determine the acceptability of the donor's past medical history, present state of health and indicated laboratory studies.

(13) “Blood component.” The following are the kinds of blood components:

Whole blood

Red blood cells

Fresh frozen plasma

Platelets concentrate

Cryoprecipitate

White cell concentrate

(14) “Blood credits” means a guarantee provided on behalf of its members by a blood bank that said blood bank will transfer to the health care facility, providing care for its member, blood units to replace the blood which was transfused to such member.

(15) “Nonreplacement fee” means a monetary fee levied by a blood bank or hospital on consumers of blood who have not or cannot provide replacement blood donors or blood credits for blood or blood components which they have used.